Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Xos Trucks specializes in the field of manufacturing fully electric commercial vehicles.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
PepGen is empowering nucleic acid therapeutics to go the distance.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Loadsmart is the end-to-end AI freight platform for shippers with embedded operational services.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
QuantumScape develops solid-state lithium-metal batteries for electric vehicles and other energy storage applications.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Inspirato is a luxury travel and lifestyle subscription company.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Wallbox is a technology company that provides electric vehicle charging and energy management solutions.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Biopharma, Life Science. The firm invests across 42 different industry categories.
Among tracked funding rounds, Avidity Biosciences received $690.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $31.3B.
Janus Henderson Investors's average investment size is $160.4M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Xos Trucks, Aktis Oncology, Pepgen, Monopar, Ventyx Biosciences. These companies were founded in 2020 or later.